You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

OMNIPEN-N Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Omnipen-n patents expire, and when can generic versions of Omnipen-n launch?

Omnipen-n is a drug marketed by Wyeth Ayerst and is included in two NDAs.

The generic ingredient in OMNIPEN-N is ampicillin sodium. There are seventy drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Omnipen-n

A generic version of OMNIPEN-N was approved as ampicillin sodium by SANDOZ on February 19th, 1987.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OMNIPEN-N?
  • What are the global sales for OMNIPEN-N?
  • What is Average Wholesale Price for OMNIPEN-N?
Summary for OMNIPEN-N
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 78
Patent Applications: 1,670
DailyMed Link:OMNIPEN-N at DailyMed
Drug patent expirations by year for OMNIPEN-N

US Patents and Regulatory Information for OMNIPEN-N

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst OMNIPEN-N ampicillin sodium INJECTABLE;INJECTION 060626-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst OMNIPEN-N ampicillin sodium INJECTABLE;INJECTION 060626-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst OMNIPEN-N ampicillin sodium INJECTABLE;INJECTION 062718-005 Dec 16, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst OMNIPEN-N ampicillin sodium INJECTABLE;INJECTION 062718-002 Dec 16, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst OMNIPEN-N ampicillin sodium INJECTABLE;INJECTION 062718-004 Dec 16, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.